Neogen (NEOG) Liabilities and Shareholders Equity (2010 - 2026)
Neogen's (NEOG) quarterly Liabilities and Shareholders Equity came in at $3.4 billion in Q1 2026, up 875.89% year-on-year from $344.2 million in Q1 2025, and little changed quarter-over-quarter from $3.4 billion in Q4 2025.
Neogen (NEOG) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Neogen's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $3.4 billion for Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 875.89% year-over-year to $3.4 billion in Q1 2026; TTM through Feb 2026 was $13.5 billion, a 48.97% increase from a year earlier, with the FY2025 full-year figure at $3.4 billion, down 24.29% from the prior year.
- Liabilities and Shareholders Equity was little changed at $3.4 billion in Q1 2026 per NEOG's latest filing, from $3.4 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $4.6 billion in Q4 2023 and bottomed at $140.2 million in Q4 2024.
- The 5-year median for Liabilities and Shareholders Equity is $3.4 billion (2025), against an average of $3.1 billion.
- Across the five-year window, Liabilities and Shareholders Equity slumped 96.95% in 2024 and jumped 2296.01% in 2025, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $4.6 billion in 2022, then climbed by 0.86% to $4.6 billion in 2023, then slumped by 96.95% to $140.2 million in 2024, then soared by 2296.01% to $3.4 billion in 2025, then dropped by 0.03% to $3.4 billion in 2026.
- Per Business Quant, the three latest NEOG Liabilities and Shareholders Equity figures stand at $3.4 billion (Q1 2026), $3.4 billion (Q4 2025), and $3.4 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | 13.32 Bn |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | 37.13 Bn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 6.63 Bn |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | 10.46 Bn |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | 31.92 Bn |
| 10 | Neogen | 2.07 Bn | 1.91 Bn | 99.00 Mn | 3.36 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 3.36 Bn |
| Nov 30, 2025 | 3.36 Bn |
| Aug 31, 2025 | 3.38 Bn |
| May 31, 2025 | 3.44 Bn |
| Feb 28, 2025 | 344.20 Mn |
| Nov 30, 2024 | 140.23 Mn |
| Aug 31, 2024 | 4.06 Bn |
| May 31, 2024 | 4.55 Bn |
| Feb 29, 2024 | 4.58 Bn |
| Nov 30, 2023 | 4.60 Bn |
| Aug 31, 2023 | 4.56 Bn |
| May 31, 2023 | 4.55 Bn |
| Feb 28, 2023 | 4.51 Bn |
| Nov 30, 2022 | 4.56 Bn |
| Aug 31, 2022 | 977.41 Mn |
| May 31, 2022 | 992.93 Mn |
| Feb 28, 2022 | 981.21 Mn |
| Nov 30, 2021 | 967.93 Mn |
| Aug 31, 2021 | 932.11 Mn |
| May 31, 2021 | 920.19 Mn |